Clinical Trials Logo

Breast Cancer clinical trials

View clinical trials related to Breast Cancer.

Filter by:

NCT ID: NCT03711916 Completed - Breast Cancer Clinical Trials

Post-Operative Outcomes of Low Thermal Dissection vs. Traditional Electrosurgery

Start date: March 17, 2017
Phase: N/A
Study type: Interventional

Low thermal dissection devices have been introduced as a tool to improve surgical outcomes. PlasmaBlade, a low thermal dissection device, has shown to be associated with effective cutting, and significantly lower temperature than traditional electrosurgical dissection device. Thus, low thermal devices would improve flap perfusion by decreasing the thermal injury resulted by the dissection. Looking into the use of low thermal devices in cases of mastectomy and immediate breast reconstruction has not been documented. The aim of this study is to determine if there are clinical flap perfusion, surgical site drainage, and pain scores differences between mastectomy flaps created using low thermal dissection device and those done with the standard care of Bovie cautery in order to warrant a formal study.

NCT ID: NCT03708432 Completed - Breast Cancer Clinical Trials

500mg Fulvestrant in HR+ MBC

Start date: July 15, 2017
Phase:
Study type: Observational

To study the real world use of 500mg Fulvestrant in HR+ MBC.

NCT ID: NCT03708393 Completed - Breast Cancer Clinical Trials

Imagio Feasibility Multi-Reader, Multi-Case Study

Start date: November 13, 2018
Phase: N/A
Study type: Interventional

Controlled, blinded, multi-reader, multi-case study

NCT ID: NCT03703557 Completed - Breast Cancer Clinical Trials

Isolation of Volatile Organic Compounds (VOCs) Related to the Olfactory Signature of Breast Cancer

KDOG2
Start date: July 25, 2018
Phase: N/A
Study type: Interventional

To ascertain the possibilities to isolate the breast cancer olfactive signature.

NCT ID: NCT03703492 Completed - Breast Cancer Clinical Trials

Hybrid Molecular Imaging of ER in Breast Cancer Patients With DCIS

Start date: January 3, 2019
Phase: Phase 2
Study type: Interventional

This prospective, one-arm study which will enroll participants with biopsy-proven DCIS scheduled for diagnostic breast MRI for preoperative staging/extent of disease evaluation as part of standard of care. Eligible participants will be consented for participation in the research study which includes a directed breast PET/MRI with 18F-FES. 18F-FES uptake of the known malignancy will be measured on the PET/MRI examination using standardized uptake values (SUV) and tumor-to-normal tissue ratios.

NCT ID: NCT03702712 Completed - Breast Cancer Clinical Trials

Responsiveness to Acute Changes in Exercise and Relaxation (RACER) Trial

RACER
Start date: October 15, 2018
Phase: N/A
Study type: Interventional

The purpose of this acute study is to compare the combined effects of aerobic exercise and relaxation training on fatigue and its related cognitive components, among breast cancer survivors. Participants will complete three sessions over a seven-day period in a laboratory setting.

NCT ID: NCT03702556 Completed - Breast Cancer Clinical Trials

Functional MRI Study Reconstructed Breasts

Start date: February 11, 2020
Phase: N/A
Study type: Interventional

Rationale: To study the effects of mastectomy and autologous breast reconstruction on the sensation of the (reconstructed) breast, not only the peripheral reinnervation of the breast should be studied, but also the changes that take place in the somatosensory cortex. Now that the region of interest in the brain and the somatotopy of the non-operated breast are known, studies with patients who underwent mastectomy and breast reconstruction are the next step to understand the neuroplasticity of the brain following breast surgery. Objective: To study the neuroplasticity of the brain after mastectomy and breast reconstructive surgery by assessing the somatotopy of the breast on the somatosensory cortex of patients who underwent either breast reconstruction with and without nerve restoration or mastectomy without breast reconstruction. Study design: A single center imaging study carried out in Maastricht University Medical Center. Study population: A total of 30 female breast cancer patients who underwent a unilateral mastectomy without breast reconstruction or a mastectomy followed by a unilateral autologous breast reconstruction with a deep inferior epigastric artery perforator (DIEP) flap will be included in this study. Three groups of patients will be selected and compared: ten patients who underwent a mastectomy without breast reconstruction, ten patients who underwent a DIEP flap breast reconstruction with sensory nerve restoration of the flap and ten patients who underwent a DIEP flap without nerve restoration. Intervention: Every subject will undergo a single functional MRI scan in a 7 Tesla MRI scan at least six months after the operation. A scanning session takes approximately 75 minutes. During the scan, piezo-electric stimulators are applied to both the reconstructed and non-operated breast in a fixed pattern. These stimulators stimulate the skin and sensory nerves of the breast and nipple-areola complex in a random sequence. Main study parameters: The hemodynamic response after stimulation of the skin of the breast and nipple-areola complex, representing neuronal activity in that region, is measured. Within the somatosensory cortex (S1 and S2), the temporo-spatial brain activity patterns after the various stimulation conditions are assessed, and the representation of the breast on the somatosensory cortex is mapped.

NCT ID: NCT03698942 Completed - Breast Cancer Clinical Trials

Delphinus SoftVue™ ROC Reader Study

DMT SV RRS1
Start date: September 23, 2018
Phase:
Study type: Observational

The purpose of this multi‐reader, multi‐case (MRMC) reader study is to evaluate reader performance when SoftVue™ automated breast ultrasound and screening mammography are combined, compared to screening mammography alone, in women with dense breast parenchyma. This includes obtaining information that can be used to properly plan, design, and power future ROC reader studies. This reader study will include a minimum of 6 radiologist readers and an enriched sample of at least 100 breast screening or diagnostic cases to be selected from the library of images collected under Delphinus Protocol #DMT‐2015.001 (NCT03257839). The reader study image case set will be enriched with cancer cases.

NCT ID: NCT03696056 Completed - Clinical trials for Breast Cancer Survivors

Improving Brain Function After Breast Cancer Study

Start date: September 28, 2018
Phase: N/A
Study type: Interventional

This study will explore the feasibility and potential effects of a simple, home-based daily meditation intervention on breast cancer survivors' cognitive and psychological functioning as well as inflammatory regulation.

NCT ID: NCT03695341 Completed - Breast Cancer Clinical Trials

500mg Fulvestrant Versus Everolimus Plus Exemestane in MBC Patients Refractory to Previous AI

Start date: May 14, 2018
Phase:
Study type: Observational

500mg Fulvestrant versus Everolimus plus Exemestane in MBC patients refractory to previous AI